A group of Democratic senators are pressing a national panel to make a move that...
Big Health's acquisition of Limbix comes at a time when many digital health comp...
The initiative comes with a $12.3 billion price tag — and over 10 years, the sav...
With momentum on Alzheimer’s therapies, Europe sees delivery challenges ahead, too.
In N.C., Mandy Cohen built bridges to the GOP. Can she find consensus as the new...
Over the past roughly 18 months, Moody’s ratings have been withdrawn on nearly $...
“This is almost biblical in its impact,” Jesse Ehrenfeld, an anesthesiologist an...
Aspartame, the popular artificial sweetener in diet sodas and chewing gums, may ...
Lawmakers passed bills on pandemic preparedness and allowing the Senate retroact...
Caribou Biosciences said its off-the-shelf CART-T therapy induced durable, compl...
A key Senate health care panel has developed a plan to tackle reforms to middlem...
In the latest edition of STAT's Health Tech newsletter: Better Therapeutics race...
Is Wegovy really a brain drug? Which Alzheimer's disease treatment works best? A...
A new study of celiac disease offers a possible explanation for how gluten can s...
Johnson & Johnson expanded global access to tuberculosis drug this week amid nov...
UnitedHealth Group’s provider arm struggled in the second quarter as more senior...
